Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2020-07-15 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled for 28th July 2020. The purpose of the meeting is to consider unaudited financial results for the quarter and half year ended 30th June 2020. The document is brief (1028 characters) and serves as an announcement rather than containing any financial data or detailed report. It is a regulatory announcement about a board meeting and financial results consideration, not the results themselves or any detailed report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2020-07-15 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed summary of the proceedings of the 64th Annual General Meeting (AGM) held on 7th July 2020, including the resolutions passed and the Scrutinizer's Report on remote e-voting. It is addressed to stock exchanges and references compliance with SEBI regulations. The content focuses on the meeting's outcomes, voting results, and appointments, which are typical of AGM-related disclosures. The document is not the full Annual Report or financial statements but a summary and voting results related to the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-07-08 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 64th Annual General Meeting ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed summary of the proceedings of the 64th Annual General Meeting (AGM) held on 7th July 2020, including the resolutions passed and the Scrutinizer's Report on voting results. It references the adoption of financial statements, dividend declarations, appointments, and remuneration approvals, all typical AGM agenda items. The document is addressed to stock exchanges and complies with SEBI regulations, indicating it is an official communication related to the AGM. It is not the full Annual Report or financial statements themselves, but a summary and voting results from the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (15,000 characters) supports it being a substantive summary rather than a brief announcement or mere notice. Hence, the classification is DVA with high confidence.
2020-07-08 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss reporting. The content is a notification of a specific event related to share certificates, not a financial report, management change, or voting result. The document length is short (1168 characters) and it is an announcement of an event rather than a report or detailed filing. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-02 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates, citing SEBI regulations. It is an intimation or notification about a specific event related to share certificates, not a financial report, management change, or other detailed filing. The document length is short (1168 characters), and it serves as a regulatory disclosure to stock exchanges. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-02 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated June 30, 2020, from Sanofi India Limited announcing the launch of an awareness initiative called 'Allergy Free' related to living with allergies during the COVID-19 pandemic. It is addressed to stock exchanges but contains no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or financial reports, and no mention of any report being attached or published. The content is purely informational and promotional about a health awareness campaign. Therefore, it does not fit into categories like Annual Report, Earnings Release, Regulatory Filings, or others related to financial or corporate governance disclosures. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement or miscellaneous filing that does not fit other categories.
2020-06-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.